XML 178 R31.htm IDEA: XBRL DOCUMENT
v3.25.1

Organization and Nature of Operations (Tables) | 3 Months Ended | 12 Months Ended
--- | --- | ---
Mar. 31, 2025 | Dec. 31, 2024
Organization and Nature of Operations [Abstract] |  |
Schedule of Consolidated Financial Statements | Details of the Company’s subsidiaries which are included in these condensed consolidated financial statements as of March 31, 2025 are as follows:
Name of Subsidiary |  | Place and Date of Incorporation |  | Percentage of Ownership |  | Principal Activities
Avalon Healthcare System, Inc. (“AHS”) |  | Delaware May 18, 2015 |  | 100% held by ALBT |  | Holding company for payroll and other expenses
Avalon RT 9 Properties LLC (“Avalon RT 9”) |  | New Jersey February 7, 2017 |  | 100% held by ALBT |  | Owns and operates an income-producing real property and holds and manages the corporate headquarters
Avalon (Shanghai) Healthcare Technology Co., Ltd. (“Avalon Shanghai”) |  | PRC April 29, 2016 |  | 100% held by AHS |  | Not considered an operating entity
Genexosome Technologies Inc. (“Genexosome”) |  | Nevada July 31, 2017 |  | 60% held by ALBT |  | No current activities to report; dormant
Avactis Biosciences Inc. (“Avactis”) |  | Nevada July 18, 2018 |  | 60% held by ALBT |  | Dormant; in process of being dissolved
Avactis Nanjing Biosciences Ltd. (“Avactis Nanjing”) |  | PRC May 8, 2020 |  | 100% held by Avactis |  | Dormant; in process of being dissolved
Avalon Laboratory Services, Inc. (“Avalon Lab”) |  | Delaware October 14, 2022 |  | 100% held by ALBT |  | No current activities to report; dormant
Q&A Distribution LLC (“Q&A Distribution”) |  | Texas May 1, 2024 |  | 100% held by ALBT |  | Distributes KetoAir device
| Details of the Company’s subsidiaries which are included in these consolidated financial statements as of December 31, 2024 are as follows:
Name of Subsidiary |  | Place and date of Incorporation |  | Percentage of Ownership |  | Principal Activities
Avalon Healthcare System, Inc. (“AHS”) |  | Delaware May 18, 2015 |  | 100% held by ALBT |  | Holding company for payroll and other expenses
Avalon RT 9 Properties LLC (“Avalon RT 9”) |  | New Jersey February 7, 2017 |  | 100% held by ALBT |  | Owns and operates an income-producing real property and holds and manages the corporate headquarters
Avalon (Shanghai) Healthcare Technology Co., Ltd. (“Avalon Shanghai”) |  | PRC April 29, 2016 |  | 100% held by AHS |  | Is not considered an operating entity
Genexosome Technologies Inc. (“Genexosome”) |  | Nevada July 31, 2017 |  | 60% held by ALBT |  | No current activities to report, dormant
Avactis Biosciences Inc. (“Avactis”) |  | Nevada July 18, 2018 |  | 60% held by ALBT |  | Dormant, is in process of being dissolved
Avactis Nanjing Biosciences Ltd. (“Avactis Nanjing”) |  | PRC May 8, 2020 |  | 100% held by Avactis |  | Dormant, is in process of being dissolved
Avalon Laboratory Services, Inc. (“Avalon Lab”) |  | Delaware October 14, 2022 |  | 100% held by ALBT |  | Laboratory holding company with a 40% membership interest in Lab Services MSO (1)
Q&A Distribution LLC (“Q&A Distribution”) |  | Texas May 1, 2024 |  | 100% held by ALBT |  | Distributes KetoAir device
(1) | On February 26, 2025, the Company and Lab Services MSO entered into a Redemption and Abandonment Agreement, whereby Lab Services MSO redeemed the 40% equity interest in Lab Services MSO held by the Company.

X
- References No definition available. + Details
Name: | us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the key aspects of a subsidiary (partnership, corporation, or other entity) of the limited liability company or limited partnership. + References No definition available. + Details
Name: | us-gaap_ScheduleOfSubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipDescriptionTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration